Vistra Corp. (NYSE:VST – Get Free Report) EVP Stephen J. Muscato sold 207,100 shares of the business’s stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $161.34, for a total value of $33,413,514.00. Following the transaction, the executive vice president now owns 318,287 shares of the company’s stock, valued at approximately $51,352,424.58. This represents a 39.42 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Vistra Trading Down 5.0 %
NYSE:VST opened at $154.54 on Thursday. The stock has a fifty day simple moving average of $129.97 and a 200 day simple moving average of $101.03. The firm has a market capitalization of $52.58 billion, a price-to-earnings ratio of 28.83, a price-to-earnings-growth ratio of 1.98 and a beta of 1.09. Vistra Corp. has a 1-year low of $34.88 and a 1-year high of $168.67. The company has a quick ratio of 0.99, a current ratio of 1.11 and a debt-to-equity ratio of 4.68.
Vistra declared that its board has authorized a stock repurchase program on Thursday, November 7th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to repurchase up to 2.1% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board believes its stock is undervalued.
Vistra Increases Dividend
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the business. Redwood Wealth Management Group LLC acquired a new stake in Vistra during the 2nd quarter worth about $26,000. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in shares of Vistra during the third quarter worth approximately $30,000. Mark Sheptoff Financial Planning LLC purchased a new position in Vistra during the third quarter valued at approximately $30,000. New Covenant Trust Company N.A. purchased a new stake in Vistra in the 1st quarter worth approximately $32,000. Finally, CVA Family Office LLC lifted its position in Vistra by 1,505.9% in the 3rd quarter. CVA Family Office LLC now owns 273 shares of the company’s stock worth $32,000 after buying an additional 256 shares in the last quarter. Hedge funds and other institutional investors own 90.88% of the company’s stock.
Wall Street Analysts Forecast Growth
VST has been the subject of a number of analyst reports. BNP Paribas assumed coverage on Vistra in a research report on Monday, October 14th. They set an “outperform” rating and a $231.00 price target for the company. Morgan Stanley upped their price objective on shares of Vistra from $135.00 to $169.00 and gave the stock an “overweight” rating in a report on Friday, November 22nd. UBS Group lowered their target price on shares of Vistra from $157.00 to $150.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Jefferies Financial Group increased their price objective on shares of Vistra from $99.00 to $137.00 and gave the company a “buy” rating in a report on Tuesday, September 24th. Finally, JPMorgan Chase & Co. initiated coverage on Vistra in a report on Thursday, October 17th. They set an “overweight” rating and a $178.00 target price on the stock. Ten analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Vistra currently has a consensus rating of “Buy” and a consensus price target of $149.10.
Check Out Our Latest Research Report on VST
About Vistra
Vistra Corp., together with its subsidiaries, operates as an integrated retail electricity and power generation company. The company operates through six segments: Retail, Texas, East, West, Sunset, and Asset Closure. It retails electricity and natural gas to residential, commercial, and industrial customers across states in the United States and the District of Columbia.
Further Reading
- Five stocks we like better than Vistra
- What to Know About Investing in Penny Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Trading Halts Explained
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Vistra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vistra and related companies with MarketBeat.com's FREE daily email newsletter.